首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells.
【24h】

Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells.

机译:人支气管上皮细胞诱导的Th2型CC趋化因子胸腺和激活调节趋化因子的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

CCR4 is now known to be selectively expressed in Th2 cells. Since the bronchial epithelium is recognized as an important source of mediators fundamental to the manifestation of respiratory allergic inflammation, we studied the expression of two functional ligands for CCR4, i.e., macrophage-derived chemokine (MDC) and thymus- and activation-regulated chemokine (TARC), in bronchial epithelial cells. The bronchial epithelium of asthmatics and normal subjects expressed TARC protein, and the asthmatics showed more intense expression than the normal subjects. On the other hand, MDC expression was only weakly detected in the asthmatics, but the intensity was not significantly different from that of normal subjects. Combination of TNF-alpha and IL-4 induced expression of TARC protein and mRNA in bronchial epithelial A549 cells, which was slightly up-regulated by IFN-gamma. The enhancement by IFN-gamma was more pronounced in bronchial epithelial BEAS-2B cells, and a maximum production occurred with combination of TNF-alpha, IL-4, and IFN-gamma. On the other hand, MDC was essentially not expressed in any of the cultures. Furthermore, expressions of TARC protein and mRNA were almost completely inhibited by glucocorticoids. These results indicate that the airway epithelium represents an important source of TARC, which potentially plays a role via a paracrine mechanism in the development of allergic respiratory diseases. Furthermore, the beneficial effect of inhaled glucocorticoids on asthma may be at least in part due to their direct inhibitory effect on TARC generation by the bronchial epithelium.
机译:现在已知CCR4在Th2细胞中选择性表达。由于支气管上皮被认为是呼吸道过敏性炎症表现的重要介质,因此我们研究了CCR4两种功能性配体的表达,即巨噬细胞衍生的趋化因子(MDC)和胸腺和活化调节的趋化因子( TARC),在支气管上皮细胞中。哮喘患者和正常人的支气管上皮表达TARC蛋白,并且哮喘患者比正常人表达更强。另一方面,仅在哮喘患者中检测到MDC表达较弱,但其强度与正常受试者没有明显差异。 TNF-α和IL-4的结合诱导了支气管上皮A549细胞中TARC蛋白和mRNA的表达,而IFN-γ上调了TARC蛋白和mRNA的表达。 IFN-γ的增强作用在支气管上皮BEAS-2B细胞中更为明显,并且TNF-α,IL-4和IFN-γ的组合产生了最大的产量。另一方面,MDC基本上在任何文化中都不表达。此外,糖皮质激素几乎完全抑制了TARC蛋白和mRNA的表达。这些结果表明,气道上皮代表TARC的重要来源,它可能通过旁分泌机制在过敏性呼吸道疾病的发展中发挥作用。此外,吸入糖皮质激素对哮喘的有益作用可能至少部分是由于它们对支气管上皮产生的TARC的直接抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号